A Randomized, Multicenter, Phase III Trial of Tacrolimus/Methotrexate versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
National Marrow Donor Program
Start Date
July 22, 2019
End Date
May 14, 2024
Administered By
Duke Cancer Institute
Awarded By
National Marrow Donor Program
Start Date
July 22, 2019
End Date
May 14, 2024